Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV000517246 | SCV000615795 | benign | not specified | 2016-12-08 | criteria provided, single submitter | clinical testing | |
Institute for Genomic Medicine |
RCV000517246 | SCV000864271 | likely benign | not specified | 2017-10-19 | criteria provided, single submitter | clinical testing | BS1, BP4; This alteration has an allele frequency that is greater than expected for the associated disease, and is predicted to be tolerated by multiple functional prediction tools. |
Invitae | RCV000921897 | SCV001067312 | benign | not provided | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000921897 | SCV001987383 | benign | not provided | 2021-10-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000921897 | SCV004149766 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | TGM6: BS2 |
Prevention |
RCV003962441 | SCV004778124 | benign | TGM6-related condition | 2020-07-01 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |